Short answer · Medically reviewed summary · Last updated: 2023-07-13
Hyperprolinemia Type II is a rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by a deficiency of the enzyme pyrroline-5-carboxylate reductase (P5CR), which is responsible for the conversion of pyrroline-5-carboxylate (P5C) to proline.
Hyperprolinemia Type II is a rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by a deficiency of the enzyme pyrroline-5-carboxylate reductase (P5CR), which is responsible for the conversion of pyrroline-5-carboxylate (P5C) to proline. Without this enzyme, P5C accumulates and leads to the symptoms associated with hyperprolinemia Type II.
While there is currently no cure for hyperprolinemia Type II, there are several treatment options available to manage the condition and alleviate symptoms:
It is important to note that the effectiveness of treatments may vary among individuals, and a personalized approach is often necessary. Regular follow-ups with healthcare professionals and adherence to recommended treatment strategies are essential for managing hyperprolinemia Type II.